rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
16
|
pubmed:dateCreated |
2008-10-14
|
pubmed:abstractText |
Aldosterone blockade is recommended for patients with congestive heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction; however, the perceived risk of hyperkalemia may limit implementation of this therapeutic approach. This subanalysis examined the relationship between eplerenone, serum potassium (K(+)), and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1524-4539
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
14
|
pubmed:volume |
118
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1643-50
|
pubmed:meshHeading |
pubmed-meshheading:18824643-Aged,
pubmed-meshheading:18824643-Aldosterone Antagonists,
pubmed-meshheading:18824643-Female,
pubmed-meshheading:18824643-Heart Failure,
pubmed-meshheading:18824643-Humans,
pubmed-meshheading:18824643-Hyperkalemia,
pubmed-meshheading:18824643-Incidence,
pubmed-meshheading:18824643-Logistic Models,
pubmed-meshheading:18824643-Male,
pubmed-meshheading:18824643-Myocardial Infarction,
pubmed-meshheading:18824643-Potassium,
pubmed-meshheading:18824643-Predictive Value of Tests,
pubmed-meshheading:18824643-Risk Factors,
pubmed-meshheading:18824643-Spironolactone,
pubmed-meshheading:18824643-Treatment Outcome,
pubmed-meshheading:18824643-Ventricular Dysfunction, Left
|
pubmed:year |
2008
|
pubmed:articleTitle |
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).
|
pubmed:affiliation |
University of Michigan Medical Center, 1500 E Medical Center Dr, Ann Arbor, MI 48109, USA. bpitt@med.umich.edu
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|